|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2010 USD | -.--% |
|
-.--% | +66.12% |
| Market Cap | 1.55M 1.33M 1.23M 1.15M 2.16M 146M 2.19M 14.5M 5.65M 71.61M 5.8M 5.68M 248M | P/E Ratio 2023 |
-25x | P/E Ratio 2024 | -5.75x |
|---|---|---|---|---|---|
| Enterprise Value | 1.06M 917K 845K 793K 1.49M 101M 1.51M 9.98M 3.89M 49.29M 4M 3.91M 171M | EV / Sales 2023 |
0.34x | EV / Sales 2024 | 0.28x |
| Free-Float |
35.53% | Yield 2023 * |
-
| Yield 2024 | - |
| 3 months | +6.91% | ||
| 6 months | +66.12% | ||
| Current year | +66.12% |
| 1 month | 0.2 |  | 0.2 |
| Current year | 0.12 | | 0.28 |
| 1 year | 0.1 | | 0.28 |
| 3 years | 0 | | 0.34 |
| 5 years | 0 | | 0.64 |
| 10 years | 0 | | 1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Justice Anderson
CEO | Chief Executive Officer | 49 | 2018-01-08 |
James Anderson
CEO | Chief Executive Officer | 56 | 2005-09-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Justice Anderson
BRD | Director/Board Member | 49 | 2005-12-31 |
James Anderson
BRD | Director/Board Member | 56 | 2006-11-30 |
Regina Anderson
CHM | Chairman | 79 | 2005-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-07-30 | Other | Director | 7,440 | 0.0918% | ||
| 24-07-30 | Other | Director | 7,200 | 0.0888% | ||
| 24-07-30 | Other | Director | 5,600 | 0.0691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +15,361.54% | -12.61% | 1.65M | |
| -0.61% | -1.94% | +39.00% | +150.72% | 1,007B | |
| -0.20% | -0.77% | +51.51% | +43.20% | 567B | |
| +0.40% | -1.31% | +16.56% | +60.47% | 392B | |
| -1.18% | +2.29% | +24.04% | +16.53% | 328B | |
| -0.43% | +1.12% | +24.21% | +31.89% | 277B | |
| +0.64% | -2.55% | +22.80% | +12.69% | 275B | |
| -1.86% | +4.01% | -43.73% | -49.21% | 196B | |
| -0.77% | +0.95% | +17.69% | +51.46% | 189B | |
| +2.36% | +1.38% | +14.80% | +61.34% | 154B | |
| Average | -0.16% | +0.55% | +1,552.84% | +36.65% | 338.6B | |
| Weighted average by Cap. | -0.31% | -0.24% | +27.44% | +67.12% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 4.69M 4.04M 3.72M 3.49M 6.56M 443M 6.63M 43.95M 17.12M 217M 17.59M 17.22M 752M | 4.98M 4.3M 3.96M 3.71M 6.97M 471M 7.05M 46.74M 18.21M 231M 18.71M 18.31M 800M |
| Net income | -50.24K -43.3K -39.87K -37.44K -70.29K -4.75M -71.03K -471K -184K -2.33M -189K -185K -8.06M | -341K -294K -271K -254K -477K -32.25M -482K -3.2M -1.25M -15.79M -1.28M -1.25M -54.74M |
| Net Debt | -427K -368K -339K -319K -598K -40.42M -604K -4.01M -1.56M -19.79M -1.6M -1.57M -68.59M | -482K -415K -383K -359K -674K -45.58M -682K -4.52M -1.76M -22.32M -1.81M -1.77M -77.35M |
Employees
20
Sector
Pharmaceuticals
- Stock Market
- Stocks
- PCYN Stock
Select your edition
All financial news and data tailored to specific country editions
